Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
Go back to Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update| Mirenco, Inc. (NASDAQ: MREO) | Delayed: 0.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.25 | 52 Week High | $0.01 | |||
| Open | $0.26 | 52 Week Low | $0.00 | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.25 | EPS | $-0.02 | |||
| Volume | 419,393 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.71 -0.17 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.88 | 52 Week High | $117.12 | |||
| Open | $14.77 | 52 Week Low | $46.52 | |||
| Day High | $15.19 | P/E | N/A | |||
| Day Low | $14.64 | EPS | $-1.97 | |||
| Volume | 860,303 | |||||
